RemeGen Co

RemeGen Co Working Capital Turnover

The Working Capital Turnover of RemeGen Co (688331.SS) as of Oct 26, 2026 is 3.10. In the previous year, Working Capital Turnover was -3.23 — a change of -195.89% (higher).

Working Capital Turnover

3.10

YoY

-195.89%

Last updated:

Working Capital Turnover of RemeGen Co is 2025 3.10 . Working Capital Turnover of RemeGen Co was 2024 -3.23 . It decreases by -195.89% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Working Capital Turnover of RemeGen Co is 3.10 in 2025.

Working Capital Turnover of RemeGen Co changed from -3.23 to 3.10, representing a -195.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Turnover RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Working capital turnover measures how efficiently a company uses its working capital to generate revenue. Higher ratios indicate more efficient short-term asset utilization.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Working Capital Turnover's RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Working Capital Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Working Capital Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — RemeGen Co

All Key Metrics — RemeGen Co